# Tunisia Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Tunisia HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Tunisia (TUN)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $60.4M
- Products: 27
- Buyer markets: 27
- Average CAGR: +8.4%
- Global sector size: $466.0B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $272.2B | $22.9M | $105.5B | -5.7% | 18 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $26.8B | $2.4M | $17.1B | +19.4% | 10 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $13.4B | $373.6K | $12.3B | -3.5% | 5 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $2.5K | $10.7B | -15.3% | 3 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $24.6B | $54.3 | $9.1B | +2.6% | 3 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $17.7B | $5.8K | $8.7B | -27.9% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $110.7K | $8.0B | +0.3% | 4 | +0.0% |
| HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $10.1B | $2.0K | $6.4B | +20.9% | 3 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $9.8B | $1.1M | $6.4B | +8.5% | 4 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $7.2B | $273.8 | $5.7B | +34.0% | 2 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $6.9B | $3.3K | $5.0B | +236.3% | 1 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $982.1K | $5.0B | +7.5% | 3 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $4.4B | $12.7 | $4.9B | +44.3% | 1 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $12.4B | $4.2K | $4.6B | -13.2% | 3 | +0.0% |
| HS 293719 - Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts | $2.3B | $39.3 | $3.1B | -3.9% | 1 | +0.0% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $3.2B | $217.7 | $2.8B | +15.3% | 2 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $2.9B | $75.0 | $2.2B | +10.7% | 2 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $3.1B | $29.8 | $2.1B | +201.4% | 1 | +0.0% |
| HS 293299 - Heterocyclic compounds: with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) | $2.4B | $4.0K | $2.0B | -34.6% | 1 | +0.0% |
| HS 310540 - Fertilizers, mineral or chemical: ammonium dihydrogenorthophosphate (monoammonium phosphate) and mixtures thereof with diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $17.7M | $1.8B | +17.3% | 1 | +0.6% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $17.1K | $1.4B | +10.5% | 1 | +0.0% |
| HS 310530 - Fertilizers, mineral or chemical: diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $14.6M | $1.3B | +13.7% | 1 | +0.5% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $1.7 | $1.1B | -14.7% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $81.5K | $989.9M | +24.0% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $81.6 | $981.1M | +6.3% | 1 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $481.0M | $1.9K | $875.2M | +21.9% | 1 | +0.0% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $6.1 | $871.2M | -17.9% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $45.3B calculated opportunity across 9 products.
- Germany (DEU): $27.8B calculated opportunity across 12 products.
- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- Netherlands (NLD): $19.2B calculated opportunity across 5 products.
- Belgium (BEL): $12.5B calculated opportunity across 4 products.
- France (FRA): $12.4B calculated opportunity across 7 products.
- Canada (CAN): $10.5B calculated opportunity across 6 products.
- China (CHN): $10.2B calculated opportunity across 4 products.
- Italy (ITA): $9.8B calculated opportunity across 2 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- United Kingdom (GBR): $9.2B calculated opportunity across 4 products.
- Spain (ESP): $8.6B calculated opportunity across 4 products.

## Growth stars

- HS 293399: +236.3% average CAGR, $5.0B calculated opportunity.
- HS 381512: +201.4% average CAGR, $2.1B calculated opportunity.
- HS 300214: +44.3% average CAGR, $4.9B calculated opportunity.
- HS 293499: +34.0% average CAGR, $5.7B calculated opportunity.
- HS 294190: +24.0% average CAGR, $989.9M calculated opportunity.
- HS 290110: +21.9% average CAGR, $875.2M calculated opportunity.
- HS 310420: +20.9% average CAGR, $6.4B calculated opportunity.
- HS 382499: +19.4% average CAGR, $17.1B calculated opportunity.
- HS 310540: +17.3% average CAGR, $1.8B calculated opportunity.
- HS 370790: +15.3% average CAGR, $2.8B calculated opportunity.

## Diversification opportunities

- HS 300490: 18 buyer markets, $105.5B calculated opportunity.
- HS 382499: 10 buyer markets, $17.1B calculated opportunity.
- HS 382600: 5 buyer markets, $12.3B calculated opportunity.
- HS 330499: 4 buyer markets, $8.0B calculated opportunity.
- HS 300439: 4 buyer markets, $6.4B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.
- HS 300215: 3 buyer markets, $9.1B calculated opportunity.
- HS 300212: 3 buyer markets, $8.7B calculated opportunity.
- HS 310420: 3 buyer markets, $6.4B calculated opportunity.
- HS 330300: 3 buyer markets, $5.0B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.